Brigaudeau C, Trimoreau F, Gachard N, Rouzier E, Jaccard A, Bordessoule D, Praloran V
Laboratoire d'Hematologie, CHRU de Limoges, France.
Br J Haematol. 1997 Mar;96(3):594-600. doi: 10.1046/j.1365-2141.1997.d01-2073.x.
Cytogenetics in multiple myeloma (MM) cases are generally difficult to perform due to the low proliferation index of malignant plasma cells (PC) in most cases. Although IL-6 and GM-CSF stimulate the in vitro proliferation of malignant plasma cells, their usefulness for improving cytogenetic results in multiple myeloma patients remains questionable, because results which compare various culture conditions in a sufficient number of patients are not available. By using a miniaturized karyotypic method, we compared in 30 multiple myeloma patients the number and percentage of clonal abnormal mitoses obtained from 3 and 6 d bone marrow cultures performed without or with two combinations of cytokines: IL-6 + GM-CSF or IL-6 + GM-CSF + IL-2 + IL-4 + TNFalpha. The percentage of patients with an abnormal karyotype, which varied with the Durie and Salmon stage of the disease, as well as the type of numerical and structural karyotypic abnormalities that we detected, were in agreement with published results. The detection of clonal karyotypic abnormalities was better after 3d of culture without cytokine than in all other culture conditions. The higher percentage of patients at all stages of MM with an abnormal karyotype in our study (76.6%) than in previous ones (20% to 60%) is largely explained by the large number of mitoses analysed in six different culture conditions due to the use of a miniaturized karyotypic method.
在多数多发性骨髓瘤(MM)病例中,由于恶性浆细胞(PC)的增殖指数较低,细胞遗传学分析通常很难进行。尽管白细胞介素-6(IL-6)和粒细胞巨噬细胞集落刺激因子(GM-CSF)能刺激恶性浆细胞的体外增殖,但它们对改善多发性骨髓瘤患者细胞遗传学结果的有效性仍存在疑问,因为尚无足够数量患者在不同培养条件下的对比结果。通过使用一种小型化核型分析方法,我们在30例多发性骨髓瘤患者中比较了在无细胞因子或添加两种细胞因子组合(IL-6 + GM-CSF或IL-6 + GM-CSF + IL-2 + IL-4 +肿瘤坏死因子α(TNFα))的情况下,3天和6天骨髓培养所获得的克隆性异常有丝分裂的数量和百分比。核型异常患者的百分比随疾病的Durie和Salmon分期而变化,我们检测到的数量和结构核型异常类型与已发表的结果一致。在无细胞因子培养3天后,克隆性核型异常的检测效果优于所有其他培养条件。本研究中处于MM各阶段的核型异常患者百分比(76.6%)高于以往研究(20%至60%),这在很大程度上是由于使用了小型化核型分析方法,在六种不同培养条件下分析了大量有丝分裂。